Standout Papers
- Strategies and challenges for the next generation of antibody–drug conjugates (2017)
- Strategies and challenges for the next generation of therapeutic antibodies (2010)
- Characterization of Therapeutic Antibodies and Related Products (2012)
- Antibody–drug conjugates come of age in oncology (2023)
- Antibody–Drug Conjugates: The Last Decade (2020)
Immediate Impact
11 by Nobel laureates 20 from Science/Nature 70 standout
Citing Papers
Effective extracellular payload release and immunomodulatory interactions govern the therapeutic effect of trastuzumab deruxtecan (T-DXd)
2025 Standout
Principles and therapeutic applications of adaptive immunity
2024 Standout
Works of Alain Beck being referenced
Antibody–drug conjugates come of age in oncology
2023 Standout
Strategies and challenges for the next generation of antibody–drug conjugates
2017 Standout
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Alain Beck | 8280 | 6944 | 3056 | 209 | 12.4k | |
| John R. Engen | 7690 | 1305 | 3235 | 194 | 11.1k | |
| William S. Hancock | 6086 | 1135 | 3935 | 232 | 8.8k | |
| Sarah Cianférani | 4783 | 1706 | 1560 | 235 | 7.0k | |
| Warren D.W. Heston | 3818 | 3542 | 759 | 150 | 10.6k | |
| Herman N. Eisen | 6054 | 4436 | 460 | 206 | 15.3k | |
| Janice M. Reichert | 5389 | 5012 | 296 | 92 | 9.4k | |
| Claude F. Meares | 3370 | 4482 | 530 | 219 | 8.5k | |
| Marcel B. Bally | 9169 | 892 | 480 | 260 | 15.0k | |
| Emanuel F. Petricoin | 6601 | 1420 | 2240 | 194 | 9.3k | |
| Brian B. Haab | 5002 | 2012 | 1341 | 106 | 6.3k |
All Works
Login with ORCID to disown or claim papers
Loading papers...